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Abstract 
Objective: To evaluate the results of a prospectively developed plan for using multiple choice questions (MCQs) developed at defined 
Bloom’s levels to assess student performance across a Therapeutics sequence.  
Methods: Faculty were prospectively instructed to prepare a specific number of MCQs for exams in a Therapeutics sequence.  
Questions were distributed into one of three cognitive levels based on a modified Bloom’s taxonomy, including recall, application, 
and analysis. Student performance on MCQs was compared between and within each Bloom’s level throughout the Therapeutics 
sequence.  In addition, correlations between MCQ performance and case performance were assessed. 
Results: A total of 168 pharmacy students were prospectively followed in a Therapeutics sequence over two years. The overall 
average MCQ score on 10 exams was 68.8%. A significant difference in student performance was observed between recall, 
application, and analysis domain averages (73.1%, 70.2% and 60.1%; p<0.001). Student performance within each Bloom’s level 
across the three courses was significantly different for recall (p<0.001), application (p<0.001), and analysis (p<0.001) MCQs.  A 
significant correlation was observed between the recall domain and the case (0.67; p<0.01), application domain and the case (0.62; 
p<0.01), and analysis domain and the case (0.64; p<0.01).   
Conclusions: As students progress through the curriculum, faculty may need to find ways to promote recall knowledge for more 
advanced topics while continuing to develop their ability to apply and analyze information. Exams with well-designed MCQs that 
prospectively target various cognitive levels can facilitate assessment of student performance.  
 
 
Background 
In pharmacy schools across the country, faculty strive to 
ensure that students are achieving course outcomes. The 
Accreditation Council for Pharmacy Education (ACPE) 
provides standards pertaining to student learning and 
assessment of learning. Standard 11 (Teaching and Learning 
Methods) states that we must foster the “development and 
maturation of critical thinking and problem-solving skills” in 
our students.
1
 Standard 15 (Assessment and Evaluation of  
Student Learning and Curricular Effectiveness) mandates that 
we assess this higher level learning with methods that 
“employ a variety of valid and reliable measures  
systematically and sequentially throughout the professional 
degree program.”
1
 The challenge is to appropriately develop 
courses so that assessment methods adequately measure the 
higher level abilities as well as knowledge.  Faculty should 
develop a process by which a variety of cognitive levels are 
evaluated during testing.
2 
 
One method for characterizing levels of learning was defined 
in the 1950’s by educational psychologist Benjamin Bloom.  
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In his work, Bloom proposed six hierarchical and cumulative 
levels of student learning (Figure 1).
3
 Lower levels of learning 
focus on recall of information while middle levels require 
application of knowledge. Higher thinking levels involve the 
deconstruction and construction of concepts.  Applying this 
model to testing can be helpful in evaluating student 
performance at various cognitive levels.
4
 
 
An assessment plan must be constructed deliberately if 
student performance is to be measured at multiple cognitive 
levels. The use of open-ended questions may be helpful in 
assessing a student’s application or analysis abilities.  
However, it need not be the only method.  If appropriately 
constructed, multiple choice questions (MCQs) may also 
assess performance at higher levels, but specific efforts must 
be taken to ensure the targeting of various cognitive levels.  
Similarly, if student abilities are to develop across a sequence 
of courses, coordination of an assessment plan is necessary.  
This is particularly important in a team-taught course where 
faculty may develop questions without consideration of how 
other faculty may be assessing students. 
 
The advantages and disadvantages of MCQs should be 
weighed when deciding their role in a course assessment 
plan.  Perhaps the most common reason for their use is quick 
and objective grading.
5
 Electronic course management 
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systems also facilitate accurate and timely recording of 
scores.  In addition, the same question can be re-
administered to reassess or compare performance of 
individuals or groups.  While administration of MCQs may be 
simple, development of high quality questions requires a 
significant time investment, with one author estimating 1 
hour per question.
5
  Because there are a limited number of 
choices, a correct answer does not necessarily assure student 
understanding.  Item analysis, however, can provide some 
insight into the ability of a question to discriminate student 
performance.
6
 Additionally, a common perception is that 
MCQs can only test lower levels of thinking while fill-in-the-
blank, short answer, or essay questions are necessary to 
assess higher levels of thinking. However, several publications 
have documented that  MCQs can successfully be used to test 
at higher cognitive levels.
7-9
 Moreover, MCQs have been 
shown to be comparable to essay questions when used for 
higher order testing.
7
  Therefore, MCQs may be able to play a 
role in assessing students’ performance at a variety of levels, 
if deliberately incorporated into a course assessment plan. 
 
This prospective cohort study was conducted at a private six-
year pharmacy school. The college enrolls approximately 
1200 students and employs 45 full-time pharmacy practice 
faculty. The patient care sequence begins in the spring 
semester of the first professional year (year 3) with 
Pathophysiology (5-credit hour course). This is followed by 
consecutive semesters of Therapeutics course work (4-credit 
hours each) through the second and third professional years. 
Specific lecture topics assigned to each Therapeutics course 
can be found in Figure 2. Each course includes lectures 
provided by a team of faculty to approximately 175 students 
and weekly case discussions with groups of 25-30 students. 
While each course uses examinations composed of MCQs and 
application-based cases, the distribution of MCQs and case 
points varies based on course and exam. Traditionally, the 
cognitive level of a MCQ was independently decided by the 
lecturer resulting in random distribution of questions at 
unspecified levels of difficulty on each exam. This study was 
designed to evaluate the results of a prospectively developed 
plan using MCQs developed at defined Bloom’s levels to 
assess student performance across a Therapeutics sequence. 
 
Methods 
Faculty were prospectively instructed to prepare a specific 
number of MCQs for exams in a Therapeutic sequence.  
Questions were distributed into one of three cognitive levels 
based on a modified Bloom’s taxonomy, including recall, 
application, and analysis (Figure 1). “Recall” questions 
included the knowledge and comprehension cognitive levels. 
A recall question only required knowledge or basic 
understanding of a fact to answer. These exam questions may 
ask the student to identify or define factual information. 
“Application” questions required students to apply 
knowledge, whereas “analysis” questions required students 
to analyze, synthesize, or evaluate information. An 
application question required applying knowledge, perhaps 
including a calculation or interpretation of information. In 
addition, exam questions written for the application level 
may ask a student to solve a problem or classify information. 
An analysis question required interpretation of numerous 
facts to answer a multistep problem. The student must 
evaluate the problem and perform the required, implicit 
steps to determine a solution.  Each examination was 
standardized to contain a ratio of MCQs distributed as 40% 
recall, 40% application, and 20% analysis. The number and 
distribution of MCQs were evenly distributed among topics 
based on the lecture hours per topic. Each exam covered 
between 11 and 15 hours of lecture time. 
 
Investigators evaluated each MCQ and its proposed Bloom’s 
classification. If the three primary investigators agreed that 
the MCQ was written at the desired level, the question was 
accepted for use on the exam.  An independent faculty 
member was consulted on occasion for assistance in 
classifying the question. When a MCQ was not written at the 
desired level, investigators worked with faculty to re-write 
the MCQ at the desired level before inclusion on the exam. 
The percentage of questions initially written at the requested 
Bloom’s level was recorded. Question writers were 
encouraged to use a submission form to facilitate the peer 
review process which identified the question writer, lecture 
topic, question, answer, and Bloom’s level (Figure 3). 
 
Examinations were composed of two sections including a 
case and MCQs. The case component included a ½-1 page 
patient case followed by a series of fill-in-the-blank questions 
designed to challenge students with open-ended questions.  
The case comprised 20-25% of the total exam points. The 
MCQ component was completed using traditional scantron 
technology (OpScan-3, River Falls, WI), while the paper-based 
short-answer case was graded by hand. Each MCQ contained 
a question stem followed by one correct answer and three 
plausible, but incorrect choices. Negatively-phrased and K-
type MCQs were not permitted. 
 
The study included students enrolled in Therapeutics courses 
in the second and third professional years of the curriculum. 
Students repeating a course or those students who did not 
progress to the subsequent course were excluded, so that 
each student could serve as his/her own control throughout 
the study.  
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The primary outcome was the comparison of student 
performance on MCQs between each Bloom’s level 
throughout the Therapeutics sequence. One secondary 
outcome evaluated student performance across the 
Therapeutics curriculum within each Bloom’s level. This was 
undertaken to determine if there was a change in 
performance at each Bloom’s level as a student progresses 
through the curriculum.  A comparison of student 
performance on MCQs to their performance on written 
examination cases was undertaken to compare these two 
assessment methods.  It was postulated that performance at 
higher Bloom’s levels might correlate with performance on 
the written cases.  A detailed examination key was provided 
for each faculty member grading the written cases to 
facilitate consistency in grading. 
 
Student performance was measured and reported as the 
average percent correct in each Bloom’s level. An ANOVA test 
was used for the primary comparison of student performance 
in each Bloom’s level. Correlations were analyzed using the 
Pearson’s Correlation Coefficient. Exam reliability was 
calculated using the Cronbach-Alpha formula. Cronbach’s 
alpha ranges from 0 to 1.00, with values close to 1.00 
indicating high consistency. Statistical analyses were 
performed using SPSS, version 16.0 and Microsoft Excel 2007. 
This research has been reviewed and approved for exempt 
status by the St. Louis College of Pharmacy Investigational 
Review Board. 
 
Results 
This prospective evaluation included 168 pharmacy students. 
A total of 16 students were excluded either due to delay in 
progression (n=12) or withdrawal from the college (n=4) 
during the study. Ten exams were administered throughout 
the Therapeutics sequence which included a total of 116 
recall (40.1%), 114 application (39.5%), and 59 analysis 
(20.4%) MCQs.  Of the 289 MCQs in the three courses, 82.7% 
of the questions were initially written at the requested 
Bloom’s level.  A similar number of MCQs were written 
correctly at the prescribed level in each of the three courses 
(86.0%, 80.0%, 81.0%; p>0.05). The exam reliability score for 
the MCQ section ranged from 0.402 to 0.611. 
 
The overall MCQ and case average scores on the 10 exams 
were 68.8% and 62.3%, respectively. A significant difference 
in student performance was observed between recall, 
application, and analysis domain averages (73.1%, 70.2% and 
60.1%; p<0.001) (Figure 4).  In addition, when analyzing 
student performance within each Bloom’s level across the 
three Therapeutics courses, a significant difference was 
observed for recall (74.8%, 71.3%, 69.0%, p<0.001), 
application (69.4%, 64.7%, 75.5%, p<0.001), and analysis 
MCQs (54.7%, 59.8%, 66.8%, p<0.001) (Figure 5). While 
performance on analysis questions progressively improved, 
performance on recall questions worsened.   
 
A significant correlation was observed between the recall 
domain and the case (0.67; p<0.01), application domain and 
the case (0.62; p<0.01), and analysis domain and the case 
(0.64; p<0.01).  Figure 6 compares each student’s average 
scores on their recall MCQs (x axis) to their average scores on 
the cases (y axis).  The scatter plots for application and 
analysis MCQs compared to cases scores were similar. This 
suggests that the use of MCQs at each of the Bloom’s levels 
would provide a similar assessment of student performance 
as the use of cases.   
 
Discussion 
In this study, we examined how students perform in three 
modified categories based on Bloom’s taxonomy. A 
distribution of 40% recall, 40% application, and 20% analysis 
was chosen based on a previous experience in a professional 
course. Wong and colleagues studied the effectiveness of an 
exam blueprint based on Bloom’s taxonomy in a pharmacy 
curriculum within an oncology block. Varying ratios of lower 
and higher level learning MCQs were assessed across three 
exams (75:25, 50:50, 40:60). Performance on lower level 
questions did not significantly change (89%, 74%, 84%); 
however, aptitude at higher level questions did improve 
(60%, 77%, 83%).
10
 Varying the distribution of MCQs across 
cognitive levels may be appropriate if the content is narrowly 
focused or with repeat assessments over time.  We chose to 
use a fixed ratio as the content varied, often becoming more 
difficult, as the students progressed through the curriculum.  
The use of three cognitive levels was chosen for ease of 
implementation in the Therapeutics sequence.  With minor 
differences existing between some Bloom’s levels, our 
modified levels categorized MCQs in a way that highlights the 
three ways to use information for clinical problem solving. 
 
Using cases with open-ended questions does not necessarily 
assess performance at higher cognitive levels.  Our 
investigation demonstrated a significant correlation between 
performance on written cases and MCQs at each of the three 
Bloom’s levels. Further evaluation of the cognitive level of 
case questions may be necessary to ensure desired outcomes 
are achieved. Just as all MCQs do not necessarily test at the 
knowledge level, short answer case questions do not always 
test students at the application or analysis level.
11
   
 
A longitudinal investigation was performed to determine if 
student performance improved across various cognitive 
levels.  While students improved at the analysis level, their 
performance on recall level questions decreased. The 
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worsening of lower level cognitive scores may not be 
indicative of the students’ diminished ability to recall and 
apply information, rather inexperience with new and more 
advanced topic material. This suggests that critical thinking 
abilities are context dependent despite the students’ 
experiences in earlier courses. As students progress through 
the curriculum, we may need to find ways to promote recall 
knowledge for more advanced topics while continuing to 
develop their ability to apply and analyze information. In 
addition, student performance at all cognitive levels may 
improve if courses are re-designed with practice 
opportunities that promote development of these higher 
level abilities. 
 
Several limitations in methodology may affect the 
extrapolation of these data. With the absence of a control 
group, we cannot definitively conclude that the correlations 
found in this study would extrapolate to other courses, 
students, or colleges. This investigation studied the same 
students throughout a sequence of Therapeutics courses. 
While exam reliability scores were collected for overall 
assessment of exam quality, the addition of an item 
discrimination analysis, such as the point biserial metric, 
should be considered in the future to ensure the consistency 
and quality of individual MCQs. Lastly, the investigators 
reached a consensus when analyzing the cognitive level of 
exam questions and did not objectively evaluate inter-rater 
reliability. Future studies should incorporate a technique to 
determine the consistency of agreement among raters using 
a kappa statistic. 
 
Targeting MCQs at a specific Bloom’s level was a new 
experience for many faculty. Nevertheless, over 80% of 
questions were initially written at the targeted cognitive 
level.  Faculty had varying levels of experience and comfort 
with writing MCQs.  Faculty development in this area may 
improve the ability and confidence of faculty in developing 
quality student assessments.
12
 
 
Prospectively defining expectations for students may help in 
designing learning experiences and assessments.  There 
should be congruency between learning objectives and the 
MCQs which assess achievement of the objective.  In our 
study, the process of prospectively determining the level of 
MCQs was beneficial in refocusing the content and method of 
delivery.  Faculty noted that this challenged them to think of 
new ways to assess student’s abilities.  The way material is 
taught may influence how a MCQ is classified.  For example, 
while a question may appear to be written at the application 
level, it may only require students to recall information if it 
was taught in such a way that the application was done for 
the students.  Focusing on the level of performance expected 
of students may be helpful in designing optimal learning 
experiences.
13
 
 
Multiple choice questions can be useful if Bloom’s taxonomy 
is used to facilitate assessment of these abilities. Given the 
results shown in the scatterplots which showed a correlation 
between MCQ score to case score (e.g. Figure 6), it is feasible 
that each of the Bloom’s levels evaluated in this study could 
be tested with MCQs. This makes it possible to use MCQs to 
test not only recall of knowledge, but the skills required to 
analyze and apply information.  Hence, strategic use of MCQs 
can be valuable for assessments within a course, across 
courses, and may also be useful for milestone evaluations 
external to a specific course. This may be helpful in assessing 
student critical thinking and problem solving abilities that we 
hope to develop through our curriculum. 
 
Summary 
Well-designed MCQs can be a useful component of 
assessment in a Therapeutics sequence.  Exams with MCQs 
that prospectively target various cognitive levels can facilitate 
this process.  Faculty development may be necessary to 
optimize the use of MCQs as an assessment tool.  Expanding 
this process to include other didactic and experiential courses 
may be helpful in assessing our entire pharmacy curriculum. 
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Figure 1: Bloom’s Taxonomy is traditionally shown in a pyramid with lower
cognitive levels at the base and higher cognitive levels at the apex.
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Course A
• Fluid and electrolytes
• Renal disease
• Hypertension
• Lipid disorders
• Heart failure
• Coronary syndromes
• Arrhythmias
• Peripheral arterial disease
• Thromboembolism
• Stroke
• Nutrition
• Obesity
• Peptic ulcer disease
Course B
• Antibiotic Kinetics
• Pneumonia
• Endocarditis
• Abdominal infections
• Skin and tissue infection
• ENT infections
• Urinary tract infection
• Vaccinations
• Toxicology
• Hepatitis and cirrhosis
• Cystic fibrosis
• Multiple sclerosis
• Seizures
• Parkinson’s disease
Course C
• Antibiotic resistance
• Tuberculosis
• Sexually transmitted disease 
• Opportunistic infection
• HIV/AIDS
• Pediatrics
• Pain
• Solid tumors
• Leukemia and lymphomas
• Sepsis
• Nausea and vomiting
• Sedation
• Paralysis
• Geriatrics
• Transplant
Figure 2: Major topic areas in each therapeutics course evaluated 
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Author Name
Heart Failure - Exam II
Recall Content Question: 27 Answer: C
Which of the following medications is indicated in ACC/AHA stage B heart failure?
a) Eplerenone
b) Bumetanide
c) Carvedilol
d) Digoxin
Application Content Question: 13 Answer: A
Which of the following is a contraindication for spironolactone?
a) Serum creatinine=3.0mg/dL
b) Serum potassium=3.5mEq/L
c) Resting heart rate=68bpm
d) Blood pressure=130/85mmHg
Analysis Content Question: 20, 27 Answer: B
A 70 year-old female (ER weight: 80 kg) presents with to the ER with progressively worsening SOB and DOE for 24 hours. She reports no 
dizziness. Physical exam reveals bilateral crackles and 3+ bilateral peripheral edema. The patient was seen by her cardiologist two days ago 
for her regular checkup (office weight: 70 kg). Current medications include furosemide 40 mg PO daily (no recent changes), lisinopril 20 mg 
daily (no recent changes), digoxin 0.125 mg PO daily (no recent changes), and metoprolol XL 50 mg PO daily (increased from 25mg by 
cardiologist at last visit two days ago). ER vitals include: BP 140/94 mm Hg, HR 84 bpm, RR 20, and temp 98.6 F. Labs include: Na 138 mEq/L, 
K 4.4 mEq/L, Cl 101 mEq/L, CO2 24 mEq/L, BUN 12 mg/dL, SCr 1.1 mg/dL, BS 119 mg/dL, and serum digoxin 1.2 ng/mL. Her last 
echocardiogram was two months ago (EF=38%). Which of the following is the BEST approach to manage this patient’s chief complaint?
a) Decrease lisinopril to 10 mg PO daily
b) Increase furosemide to 80 mg PO daily
c) Decrease metoprolol XL to 25 mg PO daily
d) Increase digoxin to 0.25 mg PO daily
Figure 3: MCQ submission form with sample questions. 
Note: The recall question only requires knowledge that beta blockers are indicated in stage B. The application question requires 
interpretation of each parameter in view of a list of contraindications.  The analysis question requires interpretation of multiple pieces of 
data, assessment of current status of problem, and evaluation of current therapy before determining the best approach to management.
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Figure 4: Overall MCQ Performance by Bloom’s Level and Course
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Figure 5: Student Performance (%) by MCQ Type  
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Figure 6: Scatter plot of Recall: Case Correlation
 
